(she/her)
Katelyn Dinkel helps partners develop forward-looking solutions to unique and challenging problems in vaccine market dynamics and related areas. A global health specialist with over nine years of experience, she’s a thought leader on emerging vaccine markets, cross-cutting market analysis, and global market shaping during Gavi 6.0. In her current portfolio, she manages market data and analytics for HPV, PCV, rota, and RSV vaccines, including analytics to inform market dynamic supply investments from global health stakeholders; in addition, she serves as project manager for a workstream developing demand forecasts for Chikungunya vaccines and other priority antigens.
Katelyn has a background in the intersection of global health research, programming, and epidemiology, and her work combines qualitative and quantitative methods. As a graduate research assistant at Johns Hopkins University, she worked at the International Vaccine Access Center (IVAC) and the Infectious Disease Dynamics (IDD) group, studying community education, vaccine hesitancy, and pandemic epidemiology. She was also a summer associate on the Enteric and Diarrheal Diseases team under Global Health Programs at the Bill & Melinda Gates Foundation.
In addition to a Bachelor of Arts in global health and a Bachelor of Science in biological sciences from Arizona State University, she holds a Master of Health Sciences in infectious disease epidemiology from the Johns Hopkins Bloomberg School of Public Health. As a volunteer, she’s conducted HIV/STI youth outreach in Arizona and Chennai, India.
